News
First-of-its-kind systematic review on the clinical relevance of test values from the QuantiFERON-TB Gold Plus TB1 and TB2 blood collection tubes has been published // Study including 4,050 ...
Clinical evaluations of the test demonstrated an excellent level of agreement as well as high sensitivity when compared with QuantiFERON-TB Gold Plus, the most recognized, gold standard IGRA ...
QIAGEN (NYSE:QGEN) announced the launch and CE marking of QIAreach QuantiFERON-TB test for tuberculosis (TB) infection. Built on the QuantiFERON-TB Gold Plus technology, QIAreach QuantiFERON-TB is ...
QuantiFERON-TB Gold Plus (QFT-Plus), the fourth generation of the modern gold standard for TB detection, receives Chinese NMPA approval as test for active tuberculosis detection ...
QIAGEN, a leading provider of innovative diagnostic solutions, plays a pivotal role in these efforts through its groundbreaking product, the QuantiFERON-TB Gold Plus test (QFT-Plus). Early ...
The QuantiFERON-TB Gold In-Tube is a blood test designed to diagnose the mycobacterium tuberculosis (:TB) bacterium in people (both with latent tuberculosis infection and active tuberculosis ...
GERMANTOWN, Maryland, and HILDEN, Germany, January 7, 2015 /PRNewswire/ -- QuantiFERON-TB Gold Plus (QFT-Plus) builds on global TB detection leadership anchored by the success of QuantiFERON-TB ...
Data on performance of QuantiFERON-TB Gold In-Tube test (QFT) and tuberculin skin test (TST) in children with active tuberculosis from high burden countries in the context of micronutrient ...
French health system approves reimbursement of QIAGEN's QuantiFERON latent TB test - Markets Insider
HILDEN, Germany, and PARIS, June 22, 2017 /PRNewswire/ -- QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that France's Ministry of Health and Social Affairs has approved ...
QIAGEN leverages QuantiFERON ®- TB technology to advance global efforts against TB TB IGRA testing now accessible in high burden, low resource and decentralized settings Study data also showcased ...
QIAGEN Launches Novel QIAreach QuantiFERON-TB Tuberculosis Test for High-Burden Regions - MENAFN.COM
(BUSINESS WIRE )-- QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch and CE marking of QIAreach® QuantiFERON®-TB test for tuberculosis (TB) infection, in order ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results